Literature DB >> 12138413

Hypertensive emergencies: diagnosis and management.

Robert A Phillips1, Jonathan Greenblatt, Lawrence R Krakoff.   

Abstract

The treatment of hypertension is preventive medicine. This principle applies in the emergency room as well as the clinic. However, there are crucial contrasts between these two care settings related to specific goals of management for real emergencies and nonemergency conditions. In the emergency room, rapid triage is necessary to separate those who can safely be sent home for future clinic assessment from those who require immediate interventions including short stays in 24-hour observation units or hospitalization for more serious problems. This review focuses on decisions related to hypertension management in the emergency room and over brief periods of observation and treatment. Strategy is supported by evidence-based considerations whenever possible. Where outcome studies are not available, we rely on the rationale derived from relevant clinical research. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12138413     DOI: 10.1053/pcad.2002.123465

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  4 in total

1.  Nonmydriatic retinal photography in the evaluation of acute neurologic conditions.

Authors:  Samuel Bidot; Beau B Bruce; Nancy J Newman; Valérie Biousse
Journal:  Neurol Clin Pract       Date:  2013-12

2.  Hypertensive Encephalopathy.

Authors:  Olajide Williams; John C.M. Brust
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-06

Review 3.  Hypertensive crises: emergencies and urgencies.

Authors:  Donald G Vidt
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-09       Impact factor: 3.738

4.  Trends in the Incidence of Hypertensive Emergencies in US Emergency Departments From 2006 to 2013.

Authors:  Alexander T Janke; Candace D McNaughton; Aaron M Brody; Robert D Welch; Phillip D Levy
Journal:  J Am Heart Assoc       Date:  2016-12-05       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.